67488-68-0Relevant academic research and scientific papers
Rhodium-Catalyzed Asymmetric Intramolecular Hydroamination of Allenes
Berthold, Dino,Geissler, Arne G. A.,Giofré, Sabrina,Breit, Bernhard
, p. 9994 - 9997 (2019/07/04)
The rhodium-catalyzed asymmetric intramolecular hydroamination of sulfonyl amides with terminal allenes is reported. It provides selective access to 5- and 6-membered N-heterocycles, scaffolds found in a large range of different bioactive compounds. Moreover, gram scale reactions, as well as the application of suitable product transformations to natural products and key intermediates thereof are demonstrated.
A dual arylboronic acid-aminothiourea catalytic system for the asymmetric intramolecular hetero-michael reaction of α,β-unsaturated carboxylic acids
Azuma, Takumi,Murata, Akihiro,Kobayashi, Yusuke,Inokuma, Tsubasa,Takemoto, Yoshiji
, p. 4256 - 4259 (2014/10/15)
A bifunctional aminoboronic acid has been used to facilitate for the first time the intramolecular aza- and oxa-Michael reactions of α,β- unsaturated carboxylic acids. The combination of an arylboronic acid with a chiral aminothiourea allowed for these re
Total synthesis and identification of two diastereoisomers of 1-methyl-2-[N-(p-tolylsulfonyl)-2-pyrrolidinyl]ethyl β-L-fucopyranoside
E Silva, Maria Joselice,Cottier, Louis,Srivastava, Rajendra M.,Sinou, Denis,Thozet, Alain
, p. 309 - 314 (2007/10/03)
The reaction of a racemic mixture of (2R,2′S)- and (2S,2′R)-N-(p-tolylsulfonyl)-2-pyrrolidinyl-2-propanol, prepared from (S)-proline, with 2,3,4-tri-O-acetyl-α-l-fucopyranosyl trichloroacetimidate led to both diastereoisomers of the title compound after O-deacetylation.
Biphenyl derivatives and drug composition
-
, (2008/06/13)
A biphenyl derivative represented by the following general formula (1) and a pharmaceutically acceptable salt thereof: [In the formula (1), A represents a single bond, —CH2—, —CO—, —CS— or —SO2—; B represents a single bond or —CH2—; R1represents a hydrogen atom, —OH, —NR11R12(wherein R11and R12each independently represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms), —OCOCH3, or a halogen atom; R2represents a hydrogen atom or R1and R2form a group ═O together; R3represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms; provided that in the formula, the absolute configuration of the position a may be either R or S]. The compound of the present invention has considerably high safety and efficacy and is useful as, in particular, a vasopressin receptor antagonist.
